Medicis Pharmaceutical Corp (NYSE:MRX)

CAPS Rating: 3 out of 5

A specialty pharmaceutical company focused on the development and marketing of products in the United States for the treatment of dermatological, aesthetic and podiatric conditions.

Recs

0
Player Avatar GMoneyCaps (70.19) Submitted: 12/13/2011 8:34:16 PM : Outperform Start Price: $31.78 MRX Score: +8.43

12/13

Featured Broker Partners


Advertisement